CN103937759B - Biscarbonyl reductase, and coding gene and application thereof - Google Patents

Biscarbonyl reductase, and coding gene and application thereof Download PDF

Info

Publication number
CN103937759B
CN103937759B CN201410188168.XA CN201410188168A CN103937759B CN 103937759 B CN103937759 B CN 103937759B CN 201410188168 A CN201410188168 A CN 201410188168A CN 103937759 B CN103937759 B CN 103937759B
Authority
CN
China
Prior art keywords
pet
seq
alkyl
carbonyl reduction
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410188168.XA
Other languages
Chinese (zh)
Other versions
CN103937759A (en
Inventor
洪浩
詹姆斯·盖吉
陈朝勇
周炎
高峰
吕彤
郭莉娜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASYCHEM PHARMACEUTICALS (TIANJIN) Co.,Ltd.
Shanghai kailaiying Biotechnology Co., Ltd
Asymchem Laboratories Fuxin Co Ltd
Asymchem Laboratories Tianjin Co Ltd
Asymchem Laboratories Jilin Co Ltd
Asymchem Life Science Tianjin Co Ltd
Original Assignee
Asymchem Laboratories Fuxin Co Ltd
Asymchem Laboratories Tianjin Co Ltd
Asymchem Laboratories Jilin Co Ltd
Asymchem Life Science Tianjin Co Ltd
Tianjin Asymchem Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asymchem Laboratories Fuxin Co Ltd, Asymchem Laboratories Tianjin Co Ltd, Asymchem Laboratories Jilin Co Ltd, Asymchem Life Science Tianjin Co Ltd, Tianjin Asymchem Pharmaceutical Co Ltd filed Critical Asymchem Laboratories Fuxin Co Ltd
Priority to CN201410188168.XA priority Critical patent/CN103937759B/en
Publication of CN103937759A publication Critical patent/CN103937759A/en
Application granted granted Critical
Publication of CN103937759B publication Critical patent/CN103937759B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01184Carbonyl reductase (NADPH) (1.1.1.184)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a biscarbonyl reductase, and a coding gene and application thereof. The biscarbonyl reductase has one of the following amino acid sequences: 1) amino acid sequence disclosed as SEQ NO.1; or 2) SEQ NO.1-derived amino acid sequence subjected to substitution, and/or deletion and/or addition of one or more amino acids with the function of stereoselectively reducing the formula disclosed in the specification into the formula disclosed in the specification, wherein the SEQ NO.1-derived amino acid sequence has more than 80% of homology with SEQ NO.1.R1 is selected from aryl group, alkyl group, cycloalkyl group, alkyl-substituted aryl group, halogen-substituted aryl group, aryl alkyl heterocyclic group, and cycloheteroalkyl or cyclohetero alkylated alkyl group; and R2 is selected from alkyl group, cycloalkyl group, and haloalkyl group or halocycloalkyl group. The biscarbonyl reductase can reduce a diketone substrate in one step to obtain 3R,5S-dihydroxy compounds with single optical purity.

Description

Di-carbonyl reduction enzyme, its encoding gene and application
Technical field
The present invention relates to living things catalysis synthesis technical field, in particular to a kind of di-carbonyl reduction enzyme, its coding base Cause and application.
Background technology
Chiral alcohol is the important midbody compound of a class, is widely used in chiral drug and other chiral fine chemicals Synthesis.3R, 5S- dihydroxy -6- benzyloxies-hecanoic acid t-butyl ester is the suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase The crucial chiral intermediate of agent statins antilipemic drugs, the method that can pass through chemical synthesis and living things catalysis synthesis are obtained. However, by chemical synthesis 3R, there is following point in the double hydroxy products of 5S-:Chiral metal catalyst, production cost need to typically be used It is high;The optical purity of product is relatively inaccessible to require;Organic solvent is used in a large number, causes environmental pollution serious.
It is a kind of effective method to synthesize this kind of compound using living things catalysis, will the substrate containing carbonyl by specific Enzymatic be reduced to corresponding chiral alcohol.Wolberg etc. utilizes bacterium Lactobacllus brevis by a kind of β, δ-bis- carbonyls Into δ-hydroxyl, ee is 98.1% to δ-carbonyl reduction in substrate;Deoxyribose -5- phosphate aldolases (DERA) can be with acetaldehyde It is substrate with chloroacetaldehyde, two chiral centres is introduced simultaneously by two step aldehyde contracting reaction and obtains 3R, the double hydroxy products of 5S-, ee> 99.9%, de=96.6%, but deoxyribose -5- phosphate aldolase catalytic reaction production costs are higher.Guo etc. is utilized Acinetobacter species SC13874 reduction prepares 3R, 5S- dihydroxy -6- benzyloxies-capronate, but de= 63.3%.Also have been reported that itrile group hydrolase by obtaining monohydroxy intermediate R-4 cyano group -3- to 3-HGN desymmetrization Hydroxybutyric acid, then 3R, 5S- dihydroxy -6- benzyloxies-capronate is obtained through multistep reaction.It can be seen that, by Biocatalysis method The prior art of the double hydroxy products of synthesis 3R, 5S- also still suffers from some technical problems:The longer difficulty of nitrilase reaction scheme compared with Greatly, it is relatively costly;Wolberg etc. is another with additive method introducing using needing in bacterium Lactobacllus brevis synthetic methods One chiral centre;Larger with enzyme amount using needing in deoxyribose -5- phosphate aldolases (DERA) synthetic method, substrate suppresses Effect is very strong and initial reaction raw material is inflammable and explosive reagent, and industrialized production difficulty is higher.
The content of the invention
The present invention is intended to provide a kind of di-carbonyl reduction enzyme, its encoding gene and application, to simplify 3R, 5S- dihydroxies The synthesis step of compound, reduces production pollution and production cost.
To achieve these goals, according to an aspect of the invention, there is provided a kind of di-carbonyl reduction enzyme.This pair of carbonyl Reductase has one of following amino acid sequence:1) amino acid sequence of SEQ NO.1;2) by the amino acid sequence of SEQ NO.1 The replacement, and/or disappearance, and/or addition through one or several amino acid is arranged, and there is generalIt is vertical Body is optionally reduced toThe amino acid sequence by derived from SEQ NO.1 of function, and SEQ NO.1 Derivative amino acid sequence is with SEQ NO.1 with more than 80% homology, wherein, R1Selected from aromatic radical, alkyl, cycloalkyl, The miscellaneous alkanisation alkyl of alkyl-substituted aromatic radical, the aromatic radical of halogen substiuted, aralkyl heterocyclic radical, cycloheteroalkyl or ring-type, R2Choosing From alkyl, cycloalkyl, alkylhalide group or halogen cycloalkyl.
According to another aspect of the present invention, there is provided a kind of encoding gene of above-mentioned di-carbonyl reduction enzyme.
Further, above-mentioned encoding gene has the deoxynucleotide sequence of one of the following:1) the deoxidation core of SEQ NO.2 Nucleotide sequence;2) there is 80% homology with the deoxynucleotide sequence of SEQ NO.2 and the protein that encodes have willStereoselective reduction isThe deoxynucleotide sequence of function.
According to a further aspect of the invention, there is provided a kind of restructuring table of the encoding gene containing above-mentioned di-carbonyl reduction enzyme Up to carrier.
According to a further aspect of the invention, there is provided a kind of transgenosis of the encoding gene containing above-mentioned di-carbonyl reduction enzyme Clone.
According to a further aspect of the invention, there is provided a kind of transgenosis of the encoding gene containing above-mentioned di-carbonyl reduction enzyme Recombinant bacterium.
According to a further aspect of the invention, there is provided a kind of above-mentioned di-carbonyl reduction enzyme is being incited somebody to action Stereoselective reduction isIn application.
Further, di-carbonyl reduction enzyme is preparing 3R, the application in 5S- dihydroxy -6- benzyloxies-hecanoic acid t-butyl ester.
Further,For Or
It is biocatalyst using the di-carbonyl reduction enzyme (Diketoreductase, DKR) of the present invention, can be with a step also Former diketone substrate, prepares the 3R of single optical purity, and 5S- dihydroxy compounds applies it to synthesis statins Intermediate, obtains the 3R that ee values are that 99%, de values are 90% or so, and 5S- dihydroxy compounds simplifies synthesis step, reduces Production pollution and production cost, are suitable for large-scale industrial production.
Specific embodiment
It should be noted that in the case where not conflicting, the feature in embodiment and embodiment in the application can phase Mutually combine.The present invention is described in detail below in conjunction with embodiment.
The carbonyl reduction enzyme gene of the present invention, from the Rhodococcus erythropolis SK121 carbonyl reductions Enzyme has the function of di-carbonyl reduction enzyme.
According to a kind of typical embodiment of the present invention, there is provided a kind of di-carbonyl reduction enzyme.The di-carbonyl reduction enzyme has One of following amino acid sequence:1) amino acid sequence of SEQ NO.1;SEQ NO.1 are: MTELKQITVLGTGVLGSQIAYQTACHGFDVVAYDINAEVIEKAKARFDSLAAAYKAENVEGAKEGKADEALQRITYS YDLGEAVAKADLVIEAIPEDIAIKRDTYEKLATVAPEHTVFATNSSTLLPSDLKEFTGRPEKFLALHFANHVWVNNT AEVMGTESTDPAVYREVVEFAKNIGMVPIELKKEKAGYVLNSLLVPLLNAASDLLIDGIADPDMVDKTWRIGTGAPF GPFQIMDVVGLTTVYNISSQGGEKQREFADYIKKNYIDEGKLGVAVGDGFYNYKG;2) by the amino acid of SEQ NO.1 Sequence through one or several amino acid replacement, and/or disappearance, and/or addition and have willIt is vertical Body selective reduction isThe amino acid sequence by derived from SEQ NO.1 of function, and SEQ NO.1 spread out Raw amino acid sequence is with SEQ NO.1 with more than 80% homology, wherein, R1Selected from aromatic radical, alkyl, cycloalkyl, alkane Aromatic radical, the aromatic radical of halogen substiuted, aralkyl heterocyclic radical, cycloheteroalkyl or the miscellaneous alkanisation alkyl of ring-type that base replaces, R2It is selected from Alkyl, cycloalkyl, alkylhalide group or halogen cycloalkyl.Using the di-carbonyl reduction enzyme (Diketoreductase, DKR) of the present invention it is Biocatalyst, can reduce diketone substrate with a step, prepare the 3R of single optical purity, and 5S- dihydroxy compounds, by which Synthesis statins drug midbody is applied to, synthesis step is simplified, production pollution and production cost is reduced, is suitable for big rule Mould industrialized production.
According to a kind of typical embodiment of the present invention, there is provided a kind of encoding gene of above-mentioned di-carbonyl reduction enzyme, the volume Code gene has the deoxynucleotide sequence of one of the following:1) deoxynucleotide sequence of SEQ NO.2;SEQ NO.2 are: ATGACTGAACTGAAGCAGATCACCGTTCTGGGTACCGGAGTTCTCGGCTCACAGATCGCCTATCAGACCGCCTGTCA CGGTTTCGACGTCGTCGCGTACGACATCAACGCCGAGGTCATCGAAAAGGCCAAGGCTCGGTTCGACTCGTTGGCCG CGGCCTACAAGGCCGAGAACGTCGAGGGTGCCAAGGAAGGCAAGGCTGACGAAGCGCTGCAACGTATTACGTACTCG TACGATCTAGGCGAAGCCGTCGCCAAGGCCGACCTGGTCATCGAGGCAATTCCCGAGGACATCGCCATCAAGCGCGA CACCTACGAGAAGCTTGCCACGGTTGCTCCTGAGCACACGGTGTTCGCTACCAACTCCTCGACGCTGCTGCCGAGCG ATCTCAAGGAGTTCACCGGCCGTCCCGAGAAGTTCCTCGCACTGCACTTCGCAAATCACGTGTGGGTCAACAACACT GCCGAGGTCATGGGCACCGAGTCCACCGACCCCGCCGTGTACCGCGAGGTCGTCGAGTTCGCGAAGAACATCGGCAT GGTGCCGATCGAACTCAAGAAGGAGAAGGCGGGCTACGTACTCAACTCGCTCCTGGTCCCGCTCCTCAACGCGGCCT CCGACCTGCTGATCGACGGCATCGCCGATCCCGACATGGTCGACAAGACGTGGCGTATCGGCACCGGAGCCCCGTTC GGCCCCTTCCAGATCATGGACGTCGTCGGGTTGACCACCGTCTACAACATCTCCTCCCAGGGCGGCGAGAAGCAGCG CGAATTCGCCGACTACATCAAGAAGAACTACATCGACGAGGGCAAGCTCGGCGTTGCTGTCGGCGACGGCTTCTACA ACTACAAGGGCTGA;2) there is 80% homology with the deoxynucleotide sequence of SEQ NO.2 and the protein that encodes have willStereoselective reduction isThe deoxynucleotide sequence of function.
According to a kind of typical embodiment of the present invention, there is provided a kind of encoding gene containing above-mentioned di-carbonyl reduction enzyme Recombinant expression carrier.The carrier can be pET-22b (+), pET-22b (+), pET-3a (+), pET-3d (+), pET-11a (+)、pET-12a(+)、pET-14b(+)、pET-15b(+)、pET-16b(+)、pET-17b(+)、pET-19b(+)、pET-20b (+)、pET-21a(+)、pET-23a(+)、pET-23b(+)、pET-24a(+)、pET-25b(+)、pET-26b(+)、pET-27b (+)、pET-28a(+)、pET-29a(+)、pET-30a(+)、pET-31b(+)、pET-32a(+)、pET-35b(+)、pET-38b (+)、pET-39b(+)、pET-40b(+)、pET-41a(+)、pET-41b(+)、pET-42a(+)、pET-43a(+)、pET-43b (+)、pET-44a(+)、pET-49b(+)、pQE2、pQE9、pQE30、pQE31、pQE32、pQE40、pQE70、pQE80、 pRSET-A、pRSET-B、pRSET-C、pGEX-5X-1、pGEX-6p-1、pGEX-6p-2、pBV220、pBV221、pBV222、 PTrc99A, pTwin1, pEZZ18, pKK232-18, pUC-18 or pUC-19.Expression vector overexpression in Escherichia coli, The molecular weight presented on SDS-PAGE through the di-carbonyl reduction enzyme of amount expression is about 30KD, at 30 DEG C, under the conditions of pH6.0, The higher 3R of optical purity, 5S- dihydroxyl compounds can be obtained with step reduction.
Certainly, transgenic cell line including above-mentioned encoding gene, transgenosis recombinant bacterium are also in protection scope of the present invention Within.According to a kind of typical embodiment of the present invention, there is provided a kind of above-mentioned di-carbonyl reduction enzyme is being incited somebody to actionStereoselective reduction isIn application.The enzyme can reduce two with a step Ketone substrate, prepares the 3R of single optical purity, and 5S- dihydroxy compounds may apply to synthesize in the middle of statins Body.Preferably, di-carbonyl reduction enzyme is preparing 3R, applies in 5S- dihydroxy -6- benzyloxies-hecanoic acid t-butyl ester, wherein,Can be Or
Beneficial effects of the present invention are further illustrated below in conjunction with embodiment.
Embodiment 1
(1) from the cloning and expression of the di-carbonyl reduction enzyme of Rhodococcus erythropolis SK121 bacterial strains
For the ease of the expression and identification of di-carbonyl reduction enzyme gene, set in 5 ' and 3 ' ends of oligonucleotide primer The restriction enzyme site of compatibility is counted.Its primer pair is as follows:Upstream primer SEQ ID NO.3:5’- GGAATTCCATATGACCGAACTGAAACAAATCACC-3’;Downstream primer SEQ ID NO.4:5’- CCGCTCGAGACCTTTGTAGTTGTAAAAGCCGTCAC-3’.Expand to obtain gene order (SEQ ID NO.2: ATGACTGAACTGAAGCAGATCACCGTTCTGGGTACCGGAGTTCTCGGCTCACAGATCGCCTATCAGACCGCCTGTCA CGGTTTCGACGTCGTCGCGTACGACATCAACGCCGAGGTCATCGAAAAGGCCAAGGCTCGGTTCGACTCGTTGGCCG CGGCCTACAAGGCCGAGAACGTCGAGGGTGCCAAGGAAGGCAAGGCTGACGAAGCGCTGCAACGTATTACGTACTCG TACGATCTAGGCGAAGCCGTCGCCAAGGCCGACCTGGTCATCGAGGCAATTCCCGAGGACATCGCCATCAAGCGCGA CACCTACGAGAAGCTTGCCACGGTTGCTCCTGAGCACACGGTGTTCGCTACCAACTCCTCGACGCTGCTGCCGAGCG ATCTCAAGGAGTTCACCGGCCGTCCCGAGAAGTTCCTCGCACTGCACTTCGCAAATCACGTGTGGGTCAACAACACT GCCGAGGTCATGGGCACCGAGTCCACCGACCCCGCCGTGTACCGCGAGGTCGTCGAGTTCGCGAAGAACATCGGCAT GGTGCCGATCGAACTCAAGAAGGAGAAGGCGGGCTACGTACTCAACTCGCTCCTGGTCCCGCTCCTCAACGCGGCCT CCGACCTGCTGATCGACGGCATCGCCGATCCCGACATGGTCGACAAGACGTGGCGTATCGGCACCGGAGCCCCGTTC GGCCCCTTCCAGATCATGGACGTCGTCGGGTTGACCACCGTCTACAACATCTCCTCCCAGGGCGGCGAGAAGCAGCG CGAATTCGCCGACTACATCAAGAAGAACTACATCGACGAGGGCAAGCTCGGCGTTGCTGTCGGCGACGGCTTCTACA ACTACAAGGGCTGA)。
Amino acid sequence is (SEQ ID NO.1:MTELKQITVLGTGVLGSQIAYQTACHGFDVVAYDINAEVIEKAK ARFDSLAAAYKAENVEGAKEGKADEALQRITYSYDLGEAVAKADLVIEAIPEDIAIKRDTYEKLATVAPEHTVFATN SSTLLPSDLKEFTGRPEKFLALHFANHVWVNNTAEVMGTESTDPAVYREVVEFAKNIGMVPIELKKEKAGYVLNSLL VPLLNAASDLLIDGIADPDMVDKTWRIGTGAPFGPFQIMDVVGLTTVYNISSQGGEKQREFADYIKKNYIDEGKLGV AVGDGFYNYKG)。
After di-carbonyl reduction enzyme total gene synthesis, it is connected on pUC57 carriers, with Nde I and Xho I respectively by genes of interest With pET-22b (+) (pET-22b (+) can also be pET-3a (+), pET-3d (+), pET-11a (+), pET-12a (+), pET- 14b (+), pET-15b (+), pET-16b (+), pET-17b (+), pET-19b (+), pET-20b (+), pET-21a (+), pET- 23a (+), pET-23b (+), pET-24a (+), pET-25b (+), pET-26b (+), pET-27b (+), pET-28a (+), pET- 29a (+), pET-30a (+), pET-31b (+), pET-32a (+), pET-35b (+), pET-38b (+), pET-39b (+), pET- 40b (+), pET-41a (+), pET-41b (+), pET-42a (+), pET-43a (+), pET-43b (+), pET-44a (+), pET- 49b (+), pQE2, pQE9, pQE30, pQE31, pQE32, pQE40, pQE70, pQE80, pRSET-A, pRSET-B, pRSET-C, PGEX-5X-1, pGEX-6p-1, pGEX-6p-2, pBV220, pBV221, pBV222, pTrc99A, pTwin1, pEZZ18, PKK232-18, pUC-18, pUC-19) plasmid simultaneously carries out digestion, and T4DNA ligases are attached reaction, by connection product turn Change in E. coli competent DH5 α bacterial strains, coat the LB solid mediums containing ampicillin containing 50 μ g/ml In (Luria-Bertani culture mediums), 37 DEG C of overnight incubations.Single bacterium colony on the above-mentioned culture medium of picking is inoculated in containing 50 μ g/ In LB fluid nutrient mediums of the ml containing ampicillin, overnight, through plasmid extraction, PCR is identified and double digestion 37 DEG C of shaken cultivations After identification, correct cloning vector pET-22b (+)-DKR is transformed in e. coli bl21 (DE3), is coated containing 50 μ In solid LB medias of the g/ml containing ampicillin, 37 DEG C of overnight incubations.Single bacterium colony inoculation in the above-mentioned culture medium of picking In 5ml is containing LB fluid nutrient mediums of the 50 μ g/ml containing ampicillin, just identify through bacterium colony PCR (PCR) True expression vector carries out abduction delivering, and above-mentioned bacterium solution is transferred in 5ml containing LB Liquid Cultures of the 50 μ g/ml containing ampicillin In base, 37 DEG C of shaken cultivations to OD600When=0.6, IPTG (isopropylthiogalactoside) is added to be respectively to final concentration 0.02mM, 0.05mM, 0.1mM, 0.2mM, 0.4mM, 0.6mM, 0.8mM and 1.0mM, carry out abduction delivering at 18 DEG C, and set The vertical negative control for being not added with IPTG derivants.After induction 16h, bacterium solution, 8000rpm/min centrifugation 10min collects thallines is taken out.Bacterium Body Ultrasonic Cell Disruptor smudge cells, 4 DEG C, 12000rpm/min centrifugation 20min obtain supernatant and precipitation, and supernatant is with vertically Electrophoresis apparatus carries out SDS-PAGE detections.As a result find the abduction delivering di-carbonyl reduction enzyme in final concentration of 0.02mMIPTG concentration Amount it is most.For improving the expression of di-carbonyl reduction enzyme, by the e. coli bl21 containing recombinant plasmid (DE3) at IPTG ends Concentration is 0.02mM, induces 8h respectively at 37 DEG C, expresses, and while set up under the conditions of 8h and 25 DEG C of induction 16h of 30 DEG C of inductions It is not added with the negative control of IPTG derivants.After abduction delivering terminates, respectively by the induction thalline of three temperature in 8000rpm/min Centrifugation 10min collects thallines.Thalline Ultrasonic Cell Disruptor smudge cells, 4 DEG C, 12000rpm/min centrifugation 20min obtain supernatant Liquid and precipitation, supernatant carry out SDS-PAGE detections with vertical electrophoresis apparatus.As a result the double carbonyls of expression when 16h is induced for 25 DEG C are found The amount of reductase is most.
(2) from the activity identification of the di-carbonyl reduction enzyme of Rhodococcus erythropolis SK121 bacterial strains
From commercially business-like raw material or the easily ketone compounds of preparation For initial feed, wherein R1Selected from aromatic radical, alkyl, cycloalkyl, alkyl-substituted aromatic radical, the aromatic radical of halogen substiuted, virtue The miscellaneous alkanisation alkyl of alkane heterocyclic radical, cycloheteroalkyl or ring-type;R2Selected from alkyl, cycloalkyl, alkylhalide group or halogen cycloalkyl.Described Double hydroxy products are expressed by following chemical general formula:Wherein R1Selected from aromatic radical, alkyl, cycloalkyl, The miscellaneous alkanisation alkyl of alkyl-substituted aromatic radical, the aromatic radical of halogen substiuted, aralkyl heterocyclic radical, cycloheteroalkyl or ring-type;R2Choosing From alkyl, cycloalkyl, alkylhalide group or halogen cycloalkyl.
To in 500ml reaction bulbs, 10g main materials are added40ml polyethylene glycol PEG- 400, after dissolution of raw material, 360ml phosphate buffers (100mM, pH=6.0) are added, substrate is dispersed in buffer solution;Plus Ketoreductase:Add 0.3g NAD+, 41.2g ammonium formates, 0.5g coenzyme hydrogenlyase and 1g di-carbonyl reduction enzymes, system pH =6.0, and 17h is incubated in 30 ± 3 DEG C;Stop reacting with 400ml ethyl acetate, filtered with 250g diatomite, 400ml acetic acid second Ester is extracted twice, and stands a point liquid, and organic phase drying is filtered, is concentrated to give crude product, dihydroxyProduce Product 92.0%, yield 90%, ee values are more than 99.5%, de values 90.4%.
The nuclear magnetic data of products obtained therefrom is as follows:400Hz, CDCl3:δ 7.29 (m, 5H), 4.54 (s, 2H), 4.22 (m, 1H), 4.07 (m, 1H), 3.45~3.40 (m, 4H), 2.41 (d, 2H), 1.65 (t, 2H), 1.43 (S, 9H).
Products obtained therefrom mass spectrometric data is:MW=310 ± 1.
To in 500ml reaction bulbs, 10g main materials are added40ml polyethylene glycol PEG- 400, after dissolution of raw material, 360ml phosphate buffers (100mM, pH=6.0) are added, substrate is dispersed in buffer solution;Plus Ketoreductase:Add 0.3g NAD+, 41.2g ammonium formates, 0.5g coenzyme hydrogenlyase and 1g di-carbonyl reduction enzymes, system pH =6.0, and 17h is incubated in 30 ± 3 DEG C;Stop reacting with 400ml ethyl acetate, filtered with 250g diatomite, 400ml acetic acid second Ester is extracted twice, and stands a point liquid, and organic phase drying is filtered, is concentrated to give crude product, dihydroxy Product 85.0%, yield 90%, ee values are more than 90-99%, de values 80-95%.
Products obtained therefrom mass spectrometric data is:MW=282 ± 1.
To in 500ml reaction bulbs, 10g main materials are added40ml polyethylene glycol PEG-400, After dissolution of raw material, 360ml phosphate buffers (100mM, pH=6.0) are added, substrate is dispersed in buffer solution;Add 0.3g NAD+, 41.2g ammonium formate, 0.5g coenzyme hydrogenlyase and 1g di-carbonyl reduction enzymes, system pH=6.0, and in 30 ± 3 DEG C of insulation 17h;Stop reacting with 400ml ethyl acetate, filtered with 250g diatomite, 400ml ethyl acetate is extracted twice, A point liquid is stood, organic phase drying is filtered, is concentrated to give crude product, dihydroxyProduct 80% is pure Degree 98.0%, yield 90%, ee values 90-99%, de values 80-95%.
Products obtained therefrom mass spectrometric data is as follows:MW=268 ± 1.
To in 500ml reaction bulbs, 10g main materials are added40ml polyethylene glycol PEG- 400, after dissolution of raw material, 360ml phosphate buffers (100mM, pH=6.0) are added, substrate is dispersed in buffer solution;Plus Enter 0.3g NAD+, 41.2g ammonium formate, 0.5g coenzyme hydrogenlyase and 3g di-carbonyl reduction enzymes, system pH=6.0, and in 30 ± 3 DEG C of insulation 17h;Stop reacting with 400ml ethyl acetate, filtered with 250g diatomite, 400ml ethyl acetate extraction two It is secondary, a point liquid is stood, organic phase drying is filtered, is concentrated to give crude product, dihydroxyProduct 75%, purity 98.0%, yield 90%, ee values 90-99%, de values 80-95%.
Products obtained therefrom mass spectrometric data is as follows:MW=324 ± 1.
Embodiment 2
With sequence homology in embodiment 1 more than 80% di-carbonyl reduction enzyme (SEQ ID NO.5), the gene source in Rhodococcus erythropolis PR4。
For the ease of the expression and identification of di-carbonyl reduction enzyme gene, set in 5 ' and 3 ' ends of oligonucleotide primer The restriction enzyme site of compatibility is counted.Its primer pair is as follows:Upstream primer SEQ ID NO.6:5’- GGAATTCCATATGACCGAACTGAAACAAATCACC-3’;Downstream primer SEQ ID NO.7:5’- CCGCTCGAGACCTTTGTAGTTGTAAAAGCCGTCAC-3’.Expand to obtain gene order (SEQ ID NO.5: ATGACTGAACTGAAGCAGATCACCGTTCTGGGTACCGGAGTTCTCGGCTCGCAGATCGCCTATCAGACCGCCTATCA CGGATTCGACGTCGTCGCGTACGACATCAACGCCGAGGTCATCGAGAAGGCCAAGGCTCGGTTCGACTCGTTGGCCG CGGCCTACAAGGCCGAAAACGTCGAGGGCGCCAAGGAAGGCAAGGCCGACGAAGCGCTACAACGTATTACGTACTCG TACGATCTCGCCGAAGCCGTGACCAAGGCCGATCTTGTCATCGAGGCAATTCCCGAGGACTTCGCCATCAAGCGCGA CACCTACGAGAAGCTCGCGGCAGTAGCTCCTGAGCACACGGTGTTCGCAACCAACTCCTCGACGCTTCTGCCGAGCG ACCTCAAGGAGTTCACCGGCCGCCCCGAGAAGTTCCTCGCACTGCACTTCGCAAATCACGTGTGGGTCAACAACACT GCCGAGGTCATGGGCACCGAGTCCACCGACCCCGCCGTGTACCGCGAGGTCGTCGAATTCGCGAAGAACATCGGCAT GGTGCCGATCGAACTCAAGAAGGAGAAGGCGGGCTACGTACTCAACTCGCTCCTGGTCCCGCTCCTCAATGCAGCAT CCGACCTGCTGATCGACGGCATCGCCGATCCCGACATGGTCGACAAGACGTGGCGTATCGGCACCGGAGCCCCGTTC GGCCCCTTCCAGATCATGGATGTCGTCGGGTTGACCACCGTCTTCAACATCTCCTCCCAGGGCGGCGAGAAGCAGCG CGCGTTCGCCGACTACATCAAGAAGAACTACATCGACGAAGGCAAGCTCGGCGTCGCTGTCGGCGAGGGCTTCTACA ACTACAAAGGCTGA)
Amino acid sequence is (SEQ ID NO.8:MTELKQITVLGTGVLGSQIAYQTAYHGFDVVAYDINAEVIEKAK ARFDSLAAAYKAENVEGAKEGKADEALQRITYSYDLAEAVTKADLVIEAIPEDFAIKRDTYEKLAAVAPEHTVFATN SSTLLPSDLKEFTGRPEKFLALHFANHVWVNNTAEVMGTESTDPAVYREVVEFAKNIGMVPIELKKEKAGYVLNSLL VPLLNAASDLLIDGIADPDMVDKTWRIGTGAPFGPFQIMDVVGLTTVFNISSQGGEKQRAFADYIKKNYIDEGKLGV AVGEGFYNYKG)。
After di-carbonyl reduction enzyme total gene synthesis, it is connected on pUC57 carriers, with Nde I and Xho I respectively by genes of interest With pET-22b (+) (pET-22b (+) can also be pET-3a (+), pET-3d (+), pET-11a (+), pET-12a (+), pET- 14b (+), pET-15b (+), pET-16b (+), pET-17b (+), pET-19b (+), pET-20b (+), pET-21a (+), pET- 23a (+), pET-23b (+), pET-24a (+), pET-25b (+), pET-26b (+), pET-27b (+), pET-28a (+), pET- 29a (+), pET-30a (+), pET-31b (+), pET-32a (+), pET-35b (+), pET-38b (+), pET-39b (+), pET- 40b (+), pET-41a (+), pET-41b (+), pET-42a (+), pET-43a (+), pET-43b (+), pET-44a (+), pET- 49b (+), pQE2, pQE9, pQE30, pQE31, pQE32, pQE40, pQE70, pQE80, pRSET-A, pRSET-B, pRSET-C, PGEX-5X-1, pGEX-6p-1, pGEX-6p-2, pBV220, pBV221, pBV222, pTrc99A, pTwin1, pEZZ18, PKK232-18, pUC-18, pUC-19) plasmid simultaneously carries out digestion, and T4DNA ligases are attached reaction, by connection product turn Change in the competence of e.colistraindh5α, in coating containing solid LB medias of the 50 μ g/ml containing ampicillin, 37 DEG C of overnight incubations.Single bacterium colony on the above-mentioned culture medium of picking is inoculated in be trained containing LB liquid of the 50 μ g/ml containing ampicillin In foster base, overnight, through plasmid extraction, PCR is identified after identifying with double digestion 37 DEG C of shaken cultivations, by correct cloning vector PET22b (+)-DKR is transformed in e. coli bl21 (DE3), is coated and is cultivated containing LB of the 50 μ g/ml containing ampicillin In base, 37 DEG C of overnight incubations.Single bacterium colony in the above-mentioned culture medium of picking is inoculated in 5ml and contains ampicillin containing 50 μ g/ml In LB fluid nutrient mediums, identify that correct expression vector carries out abduction delivering through bacterium colony PCR, above-mentioned bacterium solution is transferred in 5ml Contain in the LB fluid nutrient mediums of ampicillin containing 50 μ g/ml, 37 DEG C of shaken cultivations to OD600When=0.6, IPTG is added to end Concentration is respectively 0.02mM, 0.05mM, 0.1mM, 0.2mM, 0.4mM, 0.6mM, 0.8mM and 1.0mM, is induced at 18 DEG C Expression, and set up the negative control for being not added with IPTG derivants.After induction 16h, bacterium solution is taken out, 8000rpm/min centrifugation 10min are received Collection thalline.Thalline Ultrasonic Cell Disruptor smudge cells, 4 DEG C, 12000rpm/min centrifugation 20min obtain supernatant and precipitation, on Clear liquid carries out SDS-PAGE detections with vertical electrophoresis apparatus.As a result find the abduction delivering in final concentration of 0.02mM IPTG concentration The amount of di-carbonyl reduction enzyme is most.For improving the expression of di-carbonyl reduction enzyme, by the e. coli bl21 containing recombinant plasmid (DE3) in the final concentration of 0.02mM of IPTG, 8h, 8h and 25 DEG C of induction 16h condition following table of 30 DEG C of inductions is induced respectively at 37 DEG C Reach, and while set up the negative control for being not added with IPTG derivants.After abduction delivering terminates, respectively by the induction thalline of three temperature 10min collects thallines are centrifuged in 8000rpm/min.Thalline Ultrasonic Cell Disruptor smudge cells, 4 DEG C, 12000rpm/min centrifugations 20min obtains supernatant and precipitation, and supernatant carries out SDS-PAGE detections with vertical electrophoresis apparatus.As a result find to induce at 25 DEG C The amount for expressing di-carbonyl reduction enzyme during 16h is most.
From commercially business-like raw material or the easily ketone compounds of preparation For initial feed, wherein R1Selected from aromatic radical;R2Selected from alkyl.Described double hydroxy products are expressed by following chemical general formula:Wherein R1Selected from aromatic radical;R2Selected from alkyl.
To in 10ml reaction bulbs, 0.05g main materials are added0.5ml polyethylene glycol PEG- 400, after dissolution of raw material, 4.5ml phosphate buffers (100mM, pH=6.0) are added, substrate is dispersed in buffer solution;Plus Enter 1.5mgNAD+, 20.6mg ammonium formates, 10mg coenzyme hydrogenlyase and 20mg di-carbonyl reduction enzymes, system pH=6.0, and 17h is incubated in 30 ± 3 DEG C;Stop reacting with 5ml ethyl acetate, filtered with 1.25g diatomite, 5ml ethyl acetate is extracted twice, A point liquid is stood, organic phase drying is filtered, is concentrated to give crude product, product83.0%, yield 90%, ee value 98%, de values 91%.
The nuclear magnetic data of products obtained therefrom is as follows:400Hz, CDCl3:δ 7.29 (m, 5H), 4.54 (s, 2H), 4.22 (m, 1H), 4.07 (m, 1H), 3.45~3.40 (m, 4H), 2.41 (d, 2H), 1.65 (t, 2H), 1.43 (S, 9H).
Products obtained therefrom mass spectrometric data is as follows:MW=310 ± 1.
Embodiment 3
With di-carbonyl reduction enzyme (SEQ ID NO.9) of the sequence homology in embodiment 1 more than 80%;, the gene is SEQ The mutant of NO.1.
For the ease of the expression and identification of di-carbonyl reduction enzyme gene, set in 5 ' and 3 ' ends of oligonucleotide primer The restriction enzyme site of compatibility is counted.Its primer pair is as follows:Upstream primer SEQ ID NO.10:5’- GGAATTCCATATGACCGAACTGAAACAAATCACC-3’;Downstream primer SEQ ID NO.11:5’- CCGCTCGAGACCTTTGTAGTTGTAAAAGCCGTCAC-3’.Expand to obtain gene order (SEQ ID NO.9: ATGACTGAACTGAAGCAGATCACCGTTCTGGGTACCGGAGTTCTCGGCTCACAGATCGCCTATCAGACCGCCTGTCA CGGTTTCGACGTCGTCGCGTACGACATCAACGCCGAGGTCATCGAAAAGGCCAAGGCTCGGTTCGACTCGTTGGCCG CGGCCTACAAGGCCGAGAACGTCGAGGGTGCCAAGGAAGGCAAGGCTGACGAAGCGCTGCAACGTATTACGTACTCG TACGATCTAGGCGAAGCCGTCGCCAAGGCCGACCTGGTCATCGAGGCAGTTCCCGAGGACATCGCCATCAAGCGCGA CACCTACGAGAAGCTTGCCACGGTTGCTCCTGAGCACACGGTGTTCGCTACCAACTCCTCGACGCTGCTGCCGAGCG ATCTCAAGGAGTTCACCGGCCGTCCCGAGAAGTTCCTCGCACTGCACTTCGCAAATCACGTGTGGGTCAACAACACT GCCGAGGTCATGGGCACCGAGTCCACCGACCCCGCCGTGTACCGCGAGGTCGTCGAGTTCGCGAAGAACATCGGCAT GGTGCCGATCGAACTCAAGAAGGAGAAGGCGGGCTACGTACTCAACTCGCTCCTGGTCCCGCTCCTCAACGCGGCCT CCGACCTGCTGATCGACGGCATCGCCGATCCCGACATGGTCGACAAGACGTGGCGTATCGGCACCGGAGCCCCGTTC GGCCCCTTCCAGATCATGGACGTCGTCGGGTTGACCACCGTCTACAACATCTCCTCCCAGGGCGGCGAGAAGCAGCG CGAATTCGCCGACTACATCAAGAAGAACTACATCGACGAGGGCAAGCTCGGCGTTGCTGTCGGCGACGGCTTCTACA ACTACAAGGGCTGA)。
Its amino acid sequence is (SEQ ID NO.12:MTELKQITVLGTGVLGSQIAYQTACHGFDVVAYDINAEVIE KAKARFDSLAAAYKAENVEGAKEGKADEALQRITYSYDLGEAVAKADLVIEAVPEDIAIKRDTYEKLATVAPEHTVF ATNSSTLLPSDLKEFTGRPEKFLALHFANHVWVNNTAEVMGTESTDPAVYREVVEFAKNIGMVPIELKKEKAGYVLN SLLVPLLNAASDLLIDGIADPDMVDKTWRIGTGAPFGPFQIMDVVGLTTVYNISSQGGEKQREFADYIKKNYIDEGK LGVAVGDGFYNYKG)。
After di-carbonyl reduction enzyme total gene synthesis, it is connected on pUC57 carriers, with Nde I and Xho I respectively by genes of interest With pET-22b (+) (pET-22b (+) can also be pET-3a (+), pET-3d (+), pET-11a (+), pET-12a (+), pET- 14b (+), pET-15b (+), pET-16b (+), pET-17b (+), pET-19b (+), pET-20b (+), pET-21a (+), pET- 23a (+), pET-23b (+), pET-24a (+), pET-25b (+), pET-26b (+), pET-27b (+), pET-28a (+), pET- 29a (+), pET-30a (+), pET-31b (+), pET-32a (+), pET-35b (+), pET-38b (+), pET-39b (+), pET- 40b (+), pET-41a (+), pET-41b (+), pET-42a (+), pET-43a (+), pET-43b (+), pET-44a (+), pET- 49b (+), pQE2, pQE9, pQE30, pQE31, pQE32, pQE40, pQE70, pQE80, pRSET-A, pRSET-B, pRSET-C, PGEX-5X-1, pGEX-6p-1, pGEX-6p-2, pBV220, pBV221, pBV222, pTrc99A, pTwin1, pEZZ18, PKK232-18, pUC-18, pUC-19) plasmid simultaneously carries out digestion, and T4DNA ligases are attached reaction, by connection product turn Change in the competence of e.colistraindh5α, in coating containing solid LB medias of the 50 μ g/ml containing ampicillin, 37 DEG C of overnight incubations.Single bacterium colony on the above-mentioned culture medium of picking is inoculated in be trained containing LB liquid of the 50 μ g/ml containing ampicillin In foster base, overnight, through plasmid extraction, PCR is identified after identifying with double digestion 37 DEG C of shaken cultivations, by correct cloning vector PET22b (+)-DKR is transformed in e. coli bl21 (DE3), coats the solid LB containing ampicillin containing 50 μ g/ml In culture medium, 37 DEG C of overnight incubations.Single bacterium colony in the above-mentioned culture medium of picking is inoculated in 5ml moulds of benzyl containing ammonia containing 50 μ g/ml In the LB fluid nutrient mediums of element, identify that correct expression vector carries out abduction delivering through bacterium colony PCR, by above-mentioned bacterium solution transfer in 5ml contains containing 50 μ g/ml in the LB fluid nutrient mediums of ampicillin, 37 DEG C of shaken cultivations to OD600When=0.6, IPTG is added extremely Final concentration is respectively 0.02mM, 0.05mM, 0.1mM, 0.2mM, 0.4mM, 0.6mM, 0.8mM and 1.0mM, is lured at 18 DEG C Expression is led, and sets up the negative control for being not added with IPTG derivants.After induction 16h, bacterium solution, 8000rpm/min centrifugation 10min is taken out Collects thalline.Thalline Ultrasonic Cell Disruptor smudge cells, 4 DEG C, 12000rpm/min centrifugation 20min obtain supernatant and precipitation, Supernatant carries out SDS-PAGE detections with vertical electrophoresis apparatus.As a result find the induction table in final concentration of 0.02mM IPTG concentration Amount up to di-carbonyl reduction enzyme is most.For improving the expression of di-carbonyl reduction enzyme, by the Escherichia coli containing recombinant plasmid BL21 (DE3) induces 8h, 8h and 25 DEG C of induction 16h condition of 30 DEG C of inductions in the final concentration of 0.02mM of IPTG respectively at 37 DEG C Lower expression, and while set up the negative control for being not added with IPTG derivants.After abduction delivering terminates, respectively by the induction of three temperature Thalline is centrifuged 10min collects thallines in 8000rpm/min.Thalline Ultrasonic Cell Disruptor smudge cells, 4 DEG C, 12000rpm/min Centrifugation 20min obtains supernatant and precipitation, and supernatant carries out SDS-PAGE detections with vertical electrophoresis apparatus.As a result find to lure at 25 DEG C The amount for expressing di-carbonyl reduction enzyme when leading 16h is most.
From commercially business-like raw material or the easily ketone compounds of preparation For initial feed, wherein R1Selected from aromatic radical;R2Selected from alkyl.Described double hydroxy products are expressed by following chemical general formula:Wherein R1 is selected from aromatic radical;R2 is selected from alkyl.
To in 10ml reaction bulbs, 0.01g main materials are added0.04ml polyethylene glycol PEG- 400, after dissolution of raw material, 0.86ml phosphate buffers (100mM, pH=6.0) are added, substrate is dispersed in buffer solution; Add 1mgNAD+, 4.12mg ammonium formates, 2mg coenzyme hydrogenlyase and 4mg di-carbonyl reduction enzymes, system pH=6.0, and in 30 ± 3 DEG C of insulation 15-24h;Stop reacting with 1ml ethyl acetate, filtered with 0.25g diatomite, 1ml ethyl acetate extraction two It is secondary, a point liquid is stood, organic phase drying is filtered, is concentrated to give crude product, product80.06%, yield 90%, ee value 99.5%, de values 90.2%.
The nuclear magnetic data of products obtained therefrom is as follows:400Hz, CDCl3:δ 7.29 (m, 5H), 4.54 (s, 2H), 4.22 (m, 1H), 4.07 (m, 1H), 3.45~3.40 (m, 4H), 2.41 (d, 2H), 1.65 (t, 2H), 1.43 (S, 9H).
Products obtained therefrom mass spectrometric data is as follows:MW=310 ± 1.
Embodiment 4:
With di-carbonyl reduction enzyme (SEQ ID NO.13) of the sequence homology in embodiment 1 more than 80%;The gene is SEQ The mutant of NO.1.
For the ease of the expression and identification of di-carbonyl reduction enzyme gene, set in 5 ' and 3 ' ends of oligonucleotide primer The restriction enzyme site of compatibility is counted.Its primer pair is as follows:Upstream primer SEQ ID NO.14:5’- GGAATTCCATATGACCGAACTGAAACAAATCACC-3’;Downstream primer SEQ ID NO.15:5’- CCGCTCGAGACCTTTGTAGTTGTAAAAGCCGTCAC-3’.Expand to obtain gene order (SEQ IDNO.13: ATGACTGAACTGAAGCAGATCACCGTTCTGGGTACCGGAGTTCTCGGCTCACAGATCGCCTATCAGACCGCCTGTCA CGGTTTCGACGTCGTCGCGTACGACATCAACGCCGAGGTCATCGAAAAGGCCAAGGCTCGGTTCGACTCGTTGGCCG CGGCCTACAAGGCCGAGAACGTCGAGGGTGCCAAGGAAGGCAAGGCTGACGAAGCGCTGCAACGTATTACGTACTCG TACGATCTAGGCGAAGCCGTCGCCAAGGCCGACCTGGTCATCGAGGCAATTCCCGAGGACATCGCCATCAAGCGCGA CACCTACGAGAAGCTTGCCACGGTTGCTCCTGAGCACACGGTGTTCGCTACCAACTCCTCGACGCTGCTGCCGAGCG ATCTCAAGGAGTTCACCGGCCGTCCCGAGAAGTTCCTCGCACTGCACTTCGCAAATCGCGTGTGGGTCAACAACACT GCCGAGGTCATGGGCACCGAGTCCACCGACCCCGCCGTGTACCGCGAGGTCGTCGAGTTCGCGAAGAACATCGGCAT GGTGCCGATCGAACTCAAGAAGGAGAAGGCGGGCTACGTACTCAACTCGCTCCTGGTCCCGCTCCTCAACGCGGCCT CCGACCTGCTGATCGACGGCATCGCCGATCCCGACATGGTCGACAAGACGTGGCGTATCGGCACCGGAGCCCCGTTC GGCCCCTTCCAGATCATGGACGTCGTCGGGTTGACCACCGTCTACAACATCTCCTCCCAGGGCGGCGAGAAGCAGCG CGAATTCGCCGACTACATCAAGAAGAACTACATCGACGAGGGCAAGCTCGGCGTTGCTGTCGGCGACGGCTTCTACA ACTACAAGGGCTGA)
Its amino acid sequence is (SEQ ID NO.16:MTELKQITVLGTGVLGSQIAYQTACHGFDVVAYDINAEVIE KAKARFDSLAAAYKAENVEGAKEGKADEALQRITYSYDLGEAVAKADLVIEAIPEDIAIKRDTYEKLATVAPEHTVF ATNSSTLLPSDLKEFTGRPEKFLALHFANRVWVNNTAEVMGTESTDPAVYREVVEFAKNIGMVPIELKKEKAGYVLN SLLVPLLNAASDLLIDGIADPDMVDKTWRIGTGAPFGPFQIMDVVGLTTVYNISSQGGEKQREFADYIKKNYIDEGK LGVAVGDGFYNYKG)。
After di-carbonyl reduction enzyme total gene synthesis, it is connected on pUC57 carriers, with Nde I and Xho I respectively by genes of interest With pET-22b (+) (pET-22b (+) can also be pET-3a (+), pET-3d (+), pET-11a (+), pET-12a (+), pET- 14b (+), pET-15b (+), pET-16b (+), pET-17b (+), pET-19b (+), pET-20b (+), pET-21a (+), pET- 23a (+), pET-23b (+), pET-24a (+), pET-25b (+), pET-26b (+), pET-27b (+), pET-28a (+), pET- 29a (+), pET-30a (+), pET-31b (+), pET-32a (+), pET-35b (+), pET-38b (+), pET-39b (+), pET- 40b (+), pET-41a (+), pET-41b (+), pET-42a (+), pET-43a (+), pET-43b (+), pET-44a (+), pET- 49b (+), pQE2, pQE9, pQE30, pQE31, pQE32, pQE40, pQE70, pQE80, pRSET-A, pRSET-B, pRSET-C, PGEX-5X-1, pGEX-6p-1, pGEX-6p-2, pBV220, pBV221, pBV222, pTrc99A, pTwin1, pEZZ18, PKK232-18, pUC-18, pUC-19) plasmid simultaneously carries out digestion, and T4DNA ligases are attached reaction, by connection product turn Change in the competence of e.colistraindh5α, in coating containing solid LB medias of the 50 μ g/ml containing ampicillin, 37 DEG C of overnight incubations.Single bacterium colony on the above-mentioned culture dish of picking is inoculated in be trained containing LB liquid of the 50 μ g/ml containing ampicillin In foster base, overnight, through plasmid extraction, PCR is identified after identifying with double digestion 37 DEG C of shaken cultivations, by correct cloning vector PET22b (+)-DKR is transformed in e. coli bl21 (DE3), coats the solid LB containing ampicillin containing 50 μ g/ml In culture medium, 37 DEG C of overnight incubations.Single bacterium colony in the above-mentioned culture medium of picking is inoculated in 5ml moulds of benzyl containing ammonia containing 50 μ g/ml In the LB fluid nutrient mediums of element, identify that correct expression vector carries out abduction delivering through bacterium colony PCR, by above-mentioned bacterium solution transfer in 5ml contains containing 50 μ g/ml in the LB fluid nutrient mediums of ampicillin, 37 DEG C of shaken cultivations to OD600When=0.6, IPTG is added extremely Final concentration is respectively 0.02mM, 0.05mM, 0.1mM, 0.2mM, 0.4mM, 0.6mM, 0.8mM and 1.0mM, is lured at 18 DEG C Expression is led, and sets up the negative control for being not added with IPTG derivants.After induction 16h, bacterium solution, 8000rpm/min centrifugation 10min is taken out Collects thalline.Thalline Ultrasonic Cell Disruptor smudge cells, 4 DEG C, 12000rpm/min centrifugation 20min obtain supernatant and precipitation, Supernatant carries out SDS-PAGE detections with vertical electrophoresis apparatus.As a result find the induction table in final concentration of 0.02mM IPTG concentration Amount up to di-carbonyl reduction enzyme is most.For improving the expression of di-carbonyl reduction enzyme, by the Escherichia coli containing recombinant plasmid BL21 (DE3) induces 8h, 8h and 25 DEG C of induction 16h condition of 30 DEG C of inductions in the final concentration of 0.02mM of IPTG respectively at 37 DEG C Lower expression, and while set up the negative control for being not added with IPTG derivants.After abduction delivering terminates, respectively by the induction of three temperature Thalline is centrifuged 10min collects thallines in 8000rpm/min.Thalline Ultrasonic Cell Disruptor smudge cells, 4 DEG C, 12000rpm/min Centrifugation 20min obtains supernatant and precipitation, and supernatant carries out SDS-PAGE detections with vertical electrophoresis apparatus.As a result find to lure at 25 DEG C The amount for expressing di-carbonyl reduction enzyme when leading 16h is most.
From commercially business-like raw material or the easily ketone compounds of preparation For initial feed, wherein R1Selected from aromatic radical;R2Selected from alkyl.Described double hydroxy products are expressed by following chemical general formula:Wherein R1Selected from aromatic radical;R2Selected from alkyl.
To in 10ml reaction bulbs, 0.01g main materials are added0.04ml polyethylene glycol PEG- 400, after dissolution of raw material, 0.86ml phosphate buffers (100mM, pH=6.0) are added, substrate is dispersed in buffer solution; Add 1mgNAD+, 4.12mg ammonium formates, 2mg coenzyme hydrogenlyase and 4mg di-carbonyl reduction enzymes, system pH=6.0, and in 30 ± 3 DEG C of insulation 15-24h;Stop reacting with 1ml ethyl acetate, filtered with 0.25g diatomite, 1ml ethyl acetate extraction two It is secondary, a point liquid is stood, organic phase drying is filtered, is concentrated to give crude product, product70%, yield 90%, ee value 100%, de values 87.95%.
The nuclear magnetic data of products obtained therefrom is as follows:400Hz, CDCl3:δ 7.29 (m, 5H), 4.54 (s, 2H), 4.22 (m, 1H), 4.07 (m, 1H), 3.45~3.40 (m, 4H), 2.41 (d, 2H), 1.65 (t, 2H), 1.43 (S, 9H).
Products obtained therefrom mass spectrometric data is as follows:MW=310 ± 1.
Embodiment 5:
With di-carbonyl reduction enzyme (SEQ ID NO.17) of the sequence homology in embodiment 1 more than 80%;The gene is SEQ The mutant of NO.1.
For the ease of the expression and identification of di-carbonyl reduction enzyme gene, set in 5 ' and 3 ' ends of oligonucleotide primer The restriction enzyme site of compatibility is counted.Its primer pair is as follows:Upstream primer SEQ ID NO.18:5’- GGAATTCCATATGACCGAACTGAAACAAATCACC-3’;Downstream primer SEQ ID NO.19:5’- CCGCTCGAGACCTTTGTAGTTGTAAAAGCCGTCAC-3’.Expand to obtain gene order (SEQ IDNO.17: ATGACTGAACTGAAGCAGATCACCGTTCTGGGTACCGGAGTTCTCGGCTCACAGATCGCCTATCAGACCGCCTGTCA CGGTTTCGACGTCGTCGCGTACGACATCAACGCCGAGGTCATCGAAAAGGCCAAGGCTCGGTTCGACTCGTTGGCCG CGGCCTACAAGGCCGAGAACGTCGAGGGTGCCAAGGAAGGCAAGGCTGACGAAGCGCTGCAACGTATTACGTACTCG TACGATCTAGGCGAAGCCGTCGCCAAGGCCGACCTGGTCATCGAGGCAATTCCCGAGGACATCGCCATCAAGCGCGA CACCTACGAGAAGCTTGCCACGGTTGCTCCTGAGCACACGGTGTTCGCTACCAACTCCTCGACGCTGCTGCCGAGCG ATCTCAAGGAGTTCACCGGCCGTCCCGAGAAGTTCCTCGCACTGCACTTCGCAAATCACGTGTGGGTCAACAACACT GCCGAGGTCATGGGCACCGAGTCCACCGACCCCGCCGTGTACCGCGAGGTCGTCGAGTTCGCGAAGAACATCGGCAT GGTGCCGATCGAACTCAAGAAGGAGAAGGCGGGCTACGTACTCAACTCGCTCCTGGTCCCGCTCCTCAACGCGGCCT CCGACCTGCTGATCGACGGCATCGCCGATCCCGACATGGTCGACAAGACGTGGCGTATCGGCACCGGAGCCCCGTTC GGCCCCTTCCAGATCATGGACATTGTCGGGTTGACCACCGTCTACAACATCTCCTCCCAGGGCGGCGAGAAGCAGCG CGAATTCGCCGACTACATCAAGAAGAACTACATCGACGAGGGCAAGCTCGGCGTTGCTGTCGGCGACGGCTTCTACA ACTACAAGGGCTGA)
Its amino acid sequence is (SEQ ID NO.20:MTELKQITVLGTGVLGSQIAYQTACHGFDVVAYDINAEVIE KAKARFDSLAAAYKAENVEGAKEGKADEALQRITYSYDLGEAVAKADLVIEAIPEDIAIKRDTYEKLATVAPEHTVF ATNSSTLLPSDLKEFTGRPEKFLALHFANHVWVNNTAEVMGTESTDPAVYREVVEFAKNIGMVPIELKKEKAGYVLN SLLVPLLNAASDLLIDGIADPDMVDKTWRIGTGAPFGPFQIMDIVGLTTVYNISSQGGEKQREFADYIKKNYIDEGK LGVAVGDGFYNYKG)。
After di-carbonyl reduction enzyme total gene synthesis, it is connected on pUC57 carriers, with Nde I and Xho I respectively by genes of interest With pET-22b (+) (pET-22b (+) can also be pET-3a (+), pET-3d (+), pET-11a (+), pET-12a (+), pET- 14b (+), pET-15b (+), pET-16b (+), pET-17b (+), pET-19b (+), pET-20b (+), pET-21a (+), pET- 23a (+), pET-23b (+), pET-24a (+), pET-25b (+), pET-26b (+), pET-27b (+), pET-28a (+), pET- 29a (+), pET-30a (+), pET-31b (+), pET-32a (+), pET-35b (+), pET-38b (+), pET-39b (+), pET- 40b (+), pET-41a (+), pET-41b (+), pET-42a (+), pET-43a (+), pET-43b (+), pET-44a (+), pET- 49b (+), pQE2, pQE9, pQE30, pQE31, pQE32, pQE40, pQE70, pQE80, pRSET-A, pRSET-B, pRSET-C, PGEX-5X-1, pGEX-6p-1, pGEX-6p-2, pBV220, pBV221, pBV222, pTrc99A, pTwin1, pEZZ18, PKK232-18, pUC-18, pUC-19) plasmid simultaneously carries out digestion, and T4DNA ligases are attached reaction, by connection product turn Change in the competence of e.colistraindh5α, in coating containing solid LB medias of the 50 μ g/ml containing ampicillin, 37 DEG C of overnight incubations.Single bacterium colony on the above-mentioned culture dish of picking is inoculated in be trained containing LB liquid of the 50 μ g/ml containing ampicillin In foster base, overnight, through plasmid extraction, PCR is identified after identifying with double digestion 37 DEG C of shaken cultivations, by correct cloning vector PET22b (+)-DKR is transformed in e. coli bl21 (DE3), coats the solid LB containing ampicillin containing 50 μ g/ml In culture medium, 37 DEG C of overnight incubations.Single bacterium colony in the above-mentioned culture medium of picking is inoculated in 5ml moulds of benzyl containing ammonia containing 50 μ g/ml In the LB fluid nutrient mediums of element, identify that correct expression vector carries out abduction delivering through bacterium colony PCR, by above-mentioned bacterium solution transfer in 5ml contains containing 50 μ g/ml in the LB fluid nutrient mediums of ampicillin, 37 DEG C of shaken cultivations to OD600When=0.6, IPTG is added extremely Final concentration is respectively 0.02mM, 0.05mM, 0.1mM, 0.2mM, 0.4mM, 0.6mM, 0.8mM and 1.0mM, is lured at 18 DEG C Expression is led, and sets up the negative control for being not added with IPTG derivants.After induction 16h, bacterium solution, 8000rpm/min centrifugation 10min is taken out Collects thalline.Thalline Ultrasonic Cell Disruptor smudge cells, 4 DEG C, 12000rpm/min centrifugation 20min obtain supernatant and precipitation, Supernatant carries out SDS-PAGE detections with vertical electrophoresis apparatus.As a result find the induction table in final concentration of 0.02mM IPTG concentration Amount up to di-carbonyl reduction enzyme is most.For improving the expression of di-carbonyl reduction enzyme, by the Escherichia coli containing recombinant plasmid BL21 (DE3) induces 8h, 8h and 25 DEG C of induction 16h condition of 30 DEG C of inductions in the final concentration of 0.02mM of IPTG respectively at 37 DEG C Lower expression, and while set up the negative control for being not added with IPTG derivants.After abduction delivering terminates, respectively by the induction of three temperature Thalline is centrifuged 10min collects thallines in 8000rpm/min.Thalline Ultrasonic Cell Disruptor smudge cells, 4 DEG C, 12000rpm/min Centrifugation 20min obtains supernatant and precipitation, and supernatant carries out SDS-PAGE detections with vertical electrophoresis apparatus.As a result find to lure at 25 DEG C The amount for expressing di-carbonyl reduction enzyme when leading 16h is most.
From commercially business-like raw material or the easily ketone compounds of preparation For initial feed, wherein R1Selected from aromatic radical;R2Selected from alkyl.Described double hydroxy products are expressed by following chemical general formula:Wherein R1Selected from aromatic radical;R2Selected from alkyl.
To in 10ml reaction bulbs, 0.01g main materials are added0.04ml polyethylene glycol PEG- 400, after dissolution of raw material, 0.86ml phosphate buffers (100mM, pH=6.0) are added, substrate is dispersed in buffer solution; Add 1mgNAD+, 4.12mg ammonium formates, 2mg coenzyme hydrogenlyase and 4mg di-carbonyl reduction enzymes, system pH=6.0, and in 30 ± 3 DEG C of insulation 15-24h;Stop reacting with 1ml ethyl acetate, filtered with 0.25g diatomite, 1ml ethyl acetate extraction two It is secondary, a point liquid is stood, organic phase drying is filtered, is concentrated to give crude product, product73.24%, yield 90%, ee value 100%, de values 88.98%.
The nuclear magnetic data of products obtained therefrom is as follows:400Hz, CDCl3:δ 7.29 (m, 5H), 4.54 (s, 2H), 4.22 (m, 1H), 4.07 (m, 1H), 3.45~3.40 (m, 4H), 2.41 (d, 2H), 1.65 (t, 2H), 1.43 (S, 9H).
Products obtained therefrom mass spectrometric data is as follows:MW=310 ± 1.
Embodiment 6:
With di-carbonyl reduction enzyme (SEQ ID NO.21) of the sequence homology in embodiment 1 more than 80%;The gene is SEQ The mutant of NO.1.
For the ease of the expression and identification of di-carbonyl reduction enzyme gene, set in 5 ' and 3 ' ends of oligonucleotide primer The restriction enzyme site of compatibility is counted.Its primer pair is as follows:Upstream primer SEQ ID NO.22:5’- GGAATTCCATATGACCGAACTGAAACAAATCACC-3’;Downstream primer SEQ ID NO.23:5’- CCGCTCGAGACCTTTGTAGTTGTAAAAGCCGTCAC-3’.Expand to obtain gene order (SEQ IDNO.21: ATGACTGAACTGAAGCAGATCACCGTTCTGGGTACCGGAGTTCTCGGCTCACAGATCGCCTATCAGACCGCCTGTCA CGGTTTCGACGTCGTCGCGTACGACATCAACGCCGAGGTCATCGAAAAGGCCAAGGCTCGGTTCGACTCGTTGGCCG CGGCCTACAAGGCCGAGAACGTCGAGGGTGCCAAGGAAGGCAAGGCTGACGAAGCGCTGCAACGTATTACGTACTCG TACGATCTAGGCGAAGCCGTCGCCAAGGCCGACCTGGTCATCGAGGCAATTCCCGAGGACATCGCCATCAAGCGCGA CACCTACGAGAAGCTTGCCACGGTTGCTCCTGAGCACACGGTGTTCGCTACCAACTCCTCGACGCTGCTGCCGAGCG ATCTCAAGGAGTTCACCGGCCGTCCCGAGAAGTTCCTCGCACTGCACTTCGCAAATCACGTGTGGGTCAACAACACT GCCGAGGTCATGGGCACCGAGTCCACCGACCCCGCCGTGTACCGCGAGGTCGTCGAGTTCGCGAAGAACATCGGCAT GGTGCCGATCGAACTCAAGAAGGAGAAGGCGGGCTACGTACTCAACTCGCTCCTGGTCCCGCTCCTCAACGCGGCCT CCGACCTGCTGATCGACGGCATCGCCGATCCCGACATGGTCGACAAGACGTGGCGTATCGGCACCGGAGCCCCGTTC GGCCCCTTCCAGATCATGGACGTCGTCGGGTTGACCACCGTCTACAACATCTCCTCCCAGGGCGGCGAGAAGCAGAA AGAATTCGCCGACTACATCAAGAAGAACTACATCGACGAGGGCAAGCTCGGCGTTGCTGTCGGCGACGGCTTCTACA ACTACAAGGGCTGA)。
Its amino acid sequence is (SEQ ID NO.24:MTELKQITVLGTGVLGSQIAYQTACHGFDVVAYDINAEVIE KAKARFDSLAAAYKAENVEGAKEGKADEALQRITYSYDLGEAVAKADLVIEAIPEDIAIKRDTYEKLATVAPEHTVF ATNSSTLLPSDLKEFTGRPEKFLALHFANHVWVNNTAEVMGTESTDPAVYREVVEFAKNIGMVPIELKKEKAGYVLN SLLVPLLNAASDLLIDGIADPDMVDKTWRIGTGAPFGPFQIMDVVGLTTVYNISSQGGEKQKEFADYIKKNYIDEGK LGVAVGDGFYNYKG)。
After di-carbonyl reduction enzyme total gene synthesis, it is connected on pUC57 carriers, with Nde I and Xho I respectively by genes of interest With pET-22b (+) (pET-22b (+) can also be pET-3a (+), pET-3d (+), pET-11a (+), pET-12a (+), pET- 14b (+), pET-15b (+), pET-16b (+), pET-17b (+), pET-19b (+), pET-20b (+), pET-21a (+), pET- 23a (+), pET-23b (+), pET-24a (+), pET-25b (+), pET-26b (+), pET-27b (+), pET-28a (+), pET- 29a (+), pET-30a (+), pET-31b (+), pET-32a (+), pET-35b (+), pET-38b (+), pET-39b (+), pET- 40b (+), pET-41a (+), pET-41b (+), pET-42a (+), pET-43a (+), pET-43b (+), pET-44a (+), pET- 49b (+), pQE2, pQE9, pQE30, pQE31, pQE32, pQE40, pQE70, pQE80, pRSET-A, pRSET-B, pRSET-C, PGEX-5X-1, pGEX-6p-1, pGEX-6p-2, pBV220, pBV221, pBV222, pTrc99A, pTwin1, pEZZ18, PKK232-18, pUC-18, pUC-19) plasmid simultaneously carries out digestion, and T4DNA ligases are attached reaction, by connection product turn Change in the competence of e.colistraindh5α, in coating containing solid LB medias of the 50 μ g/ml containing ampicillin, 37 DEG C of overnight incubations.Single bacterium colony on the above-mentioned culture medium of picking is inoculated in be trained containing LB liquid of the 50 μ g/ml containing ampicillin In foster base, overnight, through plasmid extraction, PCR is identified after identifying with double digestion 37 DEG C of shaken cultivations, by correct cloning vector PET22b (+)-DKR is transformed in e. coli bl21 (DE3), coats the solid LB containing ampicillin containing 50 μ g/ml In culture medium, 37 DEG C of overnight incubations.Single bacterium colony in the above-mentioned culture medium of picking is inoculated in 5ml moulds of benzyl containing ammonia containing 50 μ g/ml In the LB fluid nutrient mediums of element, identify that correct expression vector carries out abduction delivering through bacterium colony PCR, by above-mentioned bacterium solution transfer in 5ml contains containing 50 μ g/ml in the LB fluid nutrient mediums of ampicillin, 37 DEG C of shaken cultivations to OD600When=0.6, IPTG is added extremely Final concentration is respectively 0.02mM, 0.05mM, 0.1mM, 0.2mM, 0.4mM, 0.6mM, 0.8mM and 1.0mM, is lured at 18 DEG C Expression is led, and sets up the negative control for being not added with IPTG derivants.After induction 16h, bacterium solution, 8000rpm/min centrifugation 10min is taken out Collects thalline.Thalline Ultrasonic Cell Disruptor smudge cells, 4 DEG C, 12000rpm/min centrifugation 20min obtain supernatant and precipitation, Supernatant carries out SDS-PAGE detections with vertical electrophoresis apparatus.As a result find the induction table in final concentration of 0.02mM IPTG concentration Amount up to di-carbonyl reduction enzyme is most.For improving the expression of di-carbonyl reduction enzyme, by the Escherichia coli containing recombinant plasmid BL21 (DE3) induces 8h, 8h and 25 DEG C of induction 16h condition of 30 DEG C of inductions in the final concentration of 0.02mM of IPTG respectively at 37 DEG C Lower expression, and while set up the negative control for being not added with IPTG derivants.After abduction delivering terminates, respectively by the induction of three temperature Thalline is centrifuged 10min collects thallines in 8000rpm/min.Thalline Ultrasonic Cell Disruptor smudge cells, 4 DEG C, 12000rpm/min Centrifugation 20min obtains supernatant and precipitation, and supernatant carries out SDS-PAGE detections with vertical electrophoresis apparatus.As a result find to lure at 25 DEG C The amount for expressing di-carbonyl reduction enzyme when leading 16h is most.
From commercially business-like raw material or the easily ketone compounds of preparation For initial feed, wherein R1Selected from aromatic radical;R2Selected from alkyl.Described double hydroxy products are expressed by following chemical general formula:Wherein R1Selected from aromatic radical;R2Selected from alkyl.
To in 10ml reaction bulbs, 0.01g main materials are added0.04ml polyethylene glycol PEG- 400, after dissolution of raw material, 0.86ml phosphate buffers (100mM, pH=6.0) are added, substrate is dispersed in buffer solution; Add 1mgNAD+, 4.12mg ammonium formates, 2mg coenzyme hydrogenlyase and 4mg di-carbonyl reduction enzymes, system pH=6.0, and in 30 ± 3 DEG C of insulation 15-24h;Stop reacting with 1ml ethyl acetate, filtered with 0.25g diatomite, 1ml ethyl acetate extraction two It is secondary, a point liquid is stood, organic phase drying is filtered, is concentrated to give crude product, product72.31%, receive Rate 90%, ee values 100%, de values 89.16%.
The nuclear magnetic data of products obtained therefrom is as follows:400Hz, CDCl3:δ 7.29 (m, 5H), 4.54 (s, 2H), 4.22 (m, 1H), 4.07 (m, 1H), 3.45~3.40 (m, 4H), 2.41 (d, 2H), 1.65 (t, 2H), 1.43 (S, 9H).
Products obtained therefrom mass spectrometric data is as follows:MW=310 ± 1.
Embodiment 7
With di-carbonyl reduction enzyme (SEQ ID NO.25) of the sequence homology in embodiment 1 more than 80%;The gene is SEQ The mutant of NO.1.
For the ease of the expression and identification of di-carbonyl reduction enzyme gene, set in 5 ' and 3 ' ends of oligonucleotide primer The restriction enzyme site of compatibility is counted.Its primer pair is as follows:Upstream primer SEQ ID NO.26:5’- GGAATTCCATATGACCGAACTGAAACAAATCACC-3’;Downstream primer SEQ ID NO.27:5’- CCGCTCGAGACCTTTGTAGTTGTAAAAGCCGTCAC-3’.Expand to obtain gene order (SEQ IDNO.25: ATGACTGAACTGAAGCAGATCACCGTTCTGGGTACCGGAGTTCTCGGCTCACAGATCGCCTATCAGACCGCCTGTCA CGGTTTCGACGTCGTCGCGTACGACATCAACGCCGAGGTCATCGAAAAGGCCAAGGCTCGGTTCGACTCGTTGGCCG CGGCCTACAAGGCCGAGAACGTCGAGGGTGCCAAGGAAGGCAAGGCTGACGAAGCGCTGCAACGTATTACGTACTCG TACGATCTAGGCGAAGCCGTCGCCAAGGCCGACCTGGTCATCGAGGCAATTCCCGAGGACATCGCCATCAAGCGCGA CACCTACGAGAAGCTTGCCACGGTTGCTCCTGAGCACACGGTGTTCGCTACCAACTCCTCGACGCTGCTGCCGAGCG ATCTCAAGGAGTTCACCGGCCGTCCCGAGAAGTTCCTCGCACTGCACTTCGCAAATCACGTGTGGGTCAACAACACT GCCGAGGTCATGGGCACCGAGTCCACCGACCCCGCCGTGTACCGCGAGGTCGTCGAGTTCGCGAAGAACATCGGCAT GGTGCCGATCGAACTCAAGAAGGAGAAGGCGGGCTACGTACTCAACTCGCTCCTGGTCCCGCTCCTCAACGCGGCCT CCGACCTGCTGATCGACGGCATCGCCGATCCCGACATGGTCGACAAGACGTGGCGTATCGGCACCGGAGCCCCGTTC GGCCCCTTCCAGATCATGGACGCTGTCGGGTTGACCACCGTCTACAACATCTCCTCCCAGGGCGGCGAGAAGCAGCG CGAATTCGCCGACTACATCAAGAAGAACTACATCGACGAGGGCAAGCTCGGCGTTGCTGTCGGCGACGGCTTCTACA ACTACAAGGGCTGA)。
Its amino acid sequence is (SEQ ID NO.28:MTELKQITVLGTGVLGSQIAYQTACHGFDVVAYDINAEVIE KAKARFDSLAAAYKAENVEGAKEGKADEALQRITYSYDLGEAVAKADLVIEAIPEDIAIKRDTYEKLATVAPEHTVF ATNSSTLLPSDLKEFTGRPEKFLALHFANHVWVNNTAEVMGTESTDPAVYREVVEFAKNIGMVPIELKKEKAGYVLN SLLVPLLNAASDLLIDGIADPDMVDKTWRIGTGAPFGPFQIMDAVGLTTVYNISSQGGEKQREFADYIKKNYIDEGK LGVAVGDGFYNYKG).After di-carbonyl reduction enzyme total gene synthesis, it is connected on pUC57 carriers, respectively will with Nde I and Xho I (pET-22b (+) can also be pET-3a (+), pET-3d (+), pET-11a (+), pET-12a for genes of interest and pET-22b (+) (+), pET-14b (+), pET-15b (+), pET-16b (+), pET-17b (+), pET-19b (+), pET-20b (+), pET-21a (+), pET-23a (+), pET-23b (+), pET-24a (+), pET-25b (+), pET-26b (+), pET-27b (+), pET-28a (+), pET-29a (+), pET-30a (+), pET-31b (+), pET-32a (+), pET-35b (+), pET-38b (+), pET-39b (+), pET-40b (+), pET-41a (+), pET-41b (+), pET-42a (+), pET-43a (+), pET-43b (+), pET-44a (+), pET-49b (+), pQE2, pQE9, pQE30, pQE31, pQE32, pQE40, pQE70, pQE80, pRSET-A, pRSET-B, PRSET-C, pGEX-5X-1, pGEX-6p-1, pGEX-6p-2, pBV220, pBV221, pBV222, pTrc99A, pTwin1, PEZZ18, pKK232-18, pUC-18, pUC-19) plasmid simultaneously carries out digestion, and T4DNA ligases are attached reaction, will company Thing of practicing midwifery is transformed in the competence of e.colistraindh5α, coats the solid LB containing ampicillin containing 50 μ g/ml In culture medium, 37 DEG C of overnight incubations.Single bacterium colony on the above-mentioned culture medium of picking is inoculated in and contains ampicillin containing 50 μ g/ml In LB fluid nutrient mediums, overnight, through plasmid extraction, PCR is identified after identifying with double digestion 37 DEG C of shaken cultivations, by correct gram Grand carrier pET22b (+)-DKR is transformed in e. coli bl21 (DE3), is coated and is contained ampicillin containing 50 μ g/ml In solid LB media, 37 DEG C of overnight incubations.Single bacterium colony in the above-mentioned culture medium of picking is inoculated in 5ml and contains ammonia containing 50 μ g/ml In the LB fluid nutrient mediums of parasiticin, identify that correct expression vector carries out abduction delivering through bacterium colony PCR, by above-mentioned bacterium solution Transfer in the LB fluid nutrient mediums that 5ml contains ampicillin containing 50 μ g/ml, 37 DEG C of shaken cultivations to OD600When=0.6, add IPTG is respectively 0.02mM, 0.05mM, 0.1mM, 0.2mM, 0.4mM, 0.6mM, 0.8mM and 1.0mM to final concentration, at 18 DEG C Abduction delivering is carried out, and sets up the negative control for being not added with IPTG derivants.Induction 16h after, take out bacterium solution, 8000rpm/min from Heart 10min collects thallines.Thalline Ultrasonic Cell Disruptor smudge cells, 4 DEG C, 12000rpm/min centrifugation 20min obtain supernatant And precipitation, supernatant carries out SDS-PAGE detections with vertical electrophoresis apparatus.As a result find in final concentration of 0.02mM IPTG concentration The amount of abduction delivering di-carbonyl reduction enzyme is most.For improving the expression of di-carbonyl reduction enzyme, by the large intestine containing recombinant plasmid Bacillus BL21 (DE3) induces 8h, 8h and 25 DEG C of induction 16h of 30 DEG C of inductions in the final concentration of 0.02mM of IPTG respectively at 37 DEG C Under the conditions of express, and while set up the negative control for being not added with IPTG derivants.After abduction delivering terminates, respectively by three temperature Induction thalline is centrifuged 10min collects thallines in 8000rpm/min.Thalline Ultrasonic Cell Disruptor smudge cells, 4 DEG C, 12000rpm/ Min centrifugation 20min obtain supernatant and precipitation, and supernatant carries out SDS-PAGE detections with vertical electrophoresis apparatus.As a result find 25 DEG C induction 16h when express di-carbonyl reduction enzyme amount it is most.
From commercially business-like raw material or the easily ketone compounds of preparation For initial feed, wherein R1Selected from aromatic radical;R2Selected from alkyl.Described double hydroxy products are expressed by following chemical general formula:Wherein R1Selected from aromatic radical;R2Selected from alkyl.
To in 10ml reaction bulbs, 0.01g main materials are added0.04ml polyethylene glycol PEG- 400, after dissolution of raw material, 0.86ml phosphate buffers (100mM, pH=6.0) are added, substrate is dispersed in buffer solution; Add 1mgNAD+, 4.12mg ammonium formates, 2mg coenzyme hydrogenlyase and 4mg di-carbonyl reduction enzymes, system pH=6.0, and in 30 ± 3 DEG C of insulation 15-24h;Stop reacting with 1ml ethyl acetate, filtered with 0.25g diatomite, 1ml ethyl acetate extraction two It is secondary, a point liquid is stood, organic phase drying is filtered, is concentrated to give crude product, product56.96%, receive Rate 90%, ee values 100%, de values 92.36%.
The nuclear magnetic data of products obtained therefrom is as follows:400Hz, CDCl3:δ 7.29 (m, 5H), 4.54 (s, 2H), 4.22 (m, 1H), 4.07 (m, 1H), 3.45~3.40 (m, 4H), 2.41 (d, 2H), 1.65 (t, 2H), 1.43 (S, 9H).
Products obtained therefrom mass spectrometric data is as follows:MW=310 ± 1.
Embodiment 8
With di-carbonyl reduction enzyme (SEQ ID NO.29) of the sequence homology in embodiment 1 more than 80%;The gene is SEQ The mutant of NO.1.
For the ease of the expression and identification of di-carbonyl reduction enzyme gene, set in 5 ' and 3 ' ends of oligonucleotide primer The restriction enzyme site of compatibility is counted.Its primer pair is as follows:Upstream primer SEQ ID NO.30:5’- GGAATTCCATATGACCGAACTGAAACAAATCACC-3’;Downstream primer SEQ ID NO.31:5’- CCGCTCGAGACCTTTGTAGTTGTAAAAGCCGTCAC-3’.Expand to obtain gene order (SEQ IDNO.29: ATGACTGAACTGAAGCAGATCACCGTTCTGGGTACCGGAGTTCTCGGCTCACAGATCGCCTATCAGACCGCCTGTCA CGGTTTCGACGTCGTCGCGTACGACATCAACGCCGAGGTCATCGAAAAGGCCAAGGCTCGGTTCGACTCGTTGGCCG CGGCCTACAAGGCCGAGAACGTCGAGGGTGCCAAGGAAGGCAAGGCTGACGAAGCGCTGCAACGTATTACGTACTCG TACGATCTAGGCGAAGCCGTCGCCAAGGCCGACCTGGTCATCGAGGCAATTCCCGAGGACATCGCCATCAAGCGCGA CACCTACGAGAAGCTTGCCACGGTTGCTCCTGAGCACACGGTGTTCGCTACCAACTCCTCGACGCTGCTGCCGAGCG ATCTCAAGGAGTTCACCGGCCGTCCCGAGAAGTTCCTCGCACTGCACTTCGCAAATCACGTGTGGGTCAACAACACT GCCGAGGTCATGGGCACCGAGTCCACCGACCCCGCCGTGTACCGCGAGGTCGTCGAGTTCGCGAAGAACATCGGCAT GGTGCCGATCGAACTCAAGAAGGAGAAGGCGGGCTACGTACTCAACTCGCTCCTGGTCCCGCTCCTCAACGCGGCCT CCGACCTGCTGATCGACGGCATCGCCGATCCCGACATGGTCGACAAGACGTGGCGTATCGGCACCGGAGCCCCGTTC GGCCCCTTCCAGATCATGGACGTCGCTGGGTTGACCACCGTCTACAACATCTCCTCCCAGGGCGGCGAGAAGCAGCG CGAATTCGCCGACTACATCAAGAAGAACTACATCGACGAGGGCAAGCTCGGCGTTGCTGTCGGCGACGGCTTCTACA ACTACAAGGGCTGA)。
Its amino acid sequence is (SEQ ID NO.32:MTELKQITVLGTGVLGSQIAYQTACHGFDVVAYDINAEVIE KAKARFDSLAAAYKAENVEGAKEGKADEALQRITYSYDLGEAVAKADLVIEAIPEDIAIKRDTYEKLATVAPEHTVF ATNSSTLLPSDLKEFTGRPEKFLALHFANHVWVNNTAEVMGTESTDPAVYREVVEFAKNIGMVPIELKKEKAGYVLN SLLVPLLNAASDLLIDGIADPDMVDKTWRIGTGAPFGPFQIMDVAGLTTVYNISSQGGEKQREFADYIKKNYIDEGK LGVAVGDGFYNYKG)。
After di-carbonyl reduction enzyme total gene synthesis, it is connected on pUC57 carriers, with Nde I and Xho I respectively by genes of interest With pET-22b (+) (pET-22b (+) can also be pET-3a (+), pET-3d (+), pET-11a (+), pET-12a (+), pET- 14b (+), pET-15b (+), pET-16b (+), pET-17b (+), pET-19b (+), pET-20b (+), pET-21a (+), pET- 23a (+), pET-23b (+), pET-24a (+), pET-25b (+), pET-26b (+), pET-27b (+), pET-28a (+), pET- 29a (+), pET-30a (+), pET-31b (+), pET-32a (+), pET-35b (+), pET-38b (+), pET-39b (+), pET- 40b (+), pET-41a (+), pET-41b (+), pET-42a (+), pET-43a (+), pET-43b (+), pET-44a (+), pET- 49b (+), pQE2, pQE9, pQE30, pQE31, pQE32, pQE40, pQE70, pQE80, pRSET-A, pRSET-B, pRSET-C, PGEX-5X-1, pGEX-6p-1, pGEX-6p-2, pBV220, pBV221, pBV222, pTrc99A, pTwin1, pEZZ18, PKK232-18, pUC-18, pUC-19) plasmid simultaneously carries out digestion, and T4DNA ligases are attached reaction, by connection product turn Change in the competence of e.colistraindh5α, in coating containing solid LB medias of the 50 μ g/ml containing ampicillin, 37 DEG C of overnight incubations.Single bacterium colony on the above-mentioned culture medium of picking is inoculated in be trained containing LB liquid of the 50 μ g/ml containing ampicillin In foster base, overnight, through plasmid extraction, PCR is identified after identifying with double digestion 37 DEG C of shaken cultivations, by correct cloning vector PET22b (+)-DKR is transformed in e. coli bl21 (DE3), coats the solid LB containing ampicillin containing 50 μ g/ml In culture medium, 37 DEG C of overnight incubations.Single bacterium colony in the above-mentioned culture medium of picking is inoculated in 5ml moulds of benzyl containing ammonia containing 50 μ g/ml In the LB fluid nutrient mediums of element, identify that correct expression vector carries out abduction delivering through bacterium colony PCR, by above-mentioned bacterium solution transfer in 5ml contains containing 50 μ g/ml in the LB fluid nutrient mediums of ampicillin, 37 DEG C of shaken cultivations to OD600When=0.6, IPTG is added extremely Final concentration is respectively 0.02mM, 0.05mM, 0.1mM, 0.2mM, 0.4mM, 0.6mM, 0.8mM and 1.0mM, is lured at 18 DEG C Expression is led, and sets up the negative control for being not added with IPTG derivants.After induction 16h, bacterium solution, 8000rpm/min centrifugation 10min is taken out Collects thalline.Thalline Ultrasonic Cell Disruptor smudge cells, 4 DEG C, 12000rpm/min centrifugation 20min obtain supernatant and precipitation, Supernatant carries out SDS-PAGE detections with vertical electrophoresis apparatus.As a result find the induction table in final concentration of 0.02mM IPTG concentration Amount up to di-carbonyl reduction enzyme is most.For improving the expression of di-carbonyl reduction enzyme, by the Escherichia coli containing recombinant plasmid BL21 (DE3) induces 8h, 8h and 25 DEG C of induction 16h condition of 30 DEG C of inductions in the final concentration of 0.02mM of IPTG respectively at 37 DEG C Lower expression, and while set up the negative control for being not added with IPTG derivants.After abduction delivering terminates, respectively by the induction of three temperature Thalline is centrifuged 10min collects thallines in 8000rpm/min.Thalline Ultrasonic Cell Disruptor smudge cells, 4 DEG C, 12000rpm/min Centrifugation 20min obtains supernatant and precipitation, and supernatant carries out SDS-PAGE detections with vertical electrophoresis apparatus.As a result find to lure at 25 DEG C The amount for expressing di-carbonyl reduction enzyme when leading 16h is most.
From commercially business-like raw material or the easily ketone compounds of preparation For initial feed, wherein R1Selected from aromatic radical;R2Selected from alkyl.Described double hydroxy products are expressed by following chemical general formula:Wherein R1Selected from aromatic radical;R2Selected from alkyl.
To in 10ml reaction bulbs, 0.01g main materials are added0.04ml polyethylene glycol PEG- 400, after dissolution of raw material, 0.86ml phosphate buffers (100mM, pH=6.0) are added, substrate is dispersed in buffer solution; Add 1mgNAD+, 4.12mg ammonium formates, 2mg coenzyme hydrogenlyase and 4mg di-carbonyl reduction enzymes, system pH=6.0, and in 30 ± 3 DEG C of insulation 15-24h;Stop reacting with 1ml ethyl acetate, filtered with 0.25g diatomite, 1ml ethyl acetate extraction two It is secondary, a point liquid is stood, organic phase drying is filtered, is concentrated to give crude product, product71.94%, yield 90%, ee value 100%, de values 88.29%.
The nuclear magnetic data of products obtained therefrom is as follows:400Hz, CDCl3:δ 7.29 (m, 5H), 4.54 (s, 2H), 4.22 (m, 1H), 4.07 (m, 1H), 3.45~3.40 (m, 4H), 2.41 (d, 2H), 1.65 (t, 2H), 1.43 (S, 9H).
Products obtained therefrom mass spectrometric data is as follows:MW=310 ± 1.
As can be seen from the above description, the above embodiments of the present invention realize following technique effect:Using this Bright di-carbonyl reduction enzyme (Diketoreductase, DKR) is biocatalyst, can reduce diketone substrate with a step, be prepared into To the 3R of single optical purity, 5S- dihydroxy compounds, synthesis statins drug midbody is applied it to, simplify synthesis Step, reduces production pollution and production cost, is suitable for large-scale industrial production.
The preferred embodiments of the present invention are the foregoing is only, the present invention is not limited to, for the skill of this area For art personnel, the present invention can have various modifications and variations.It is all within the spirit and principles in the present invention, made any repair Change, equivalent, improvement etc., should be included within the scope of the present invention.

Claims (4)

1. di-carbonyl reduction enzyme is being incited somebody to actionStereoselective reduction isIn should With, wherein, R1Selected from aromatic radical, alkyl, cycloalkyl, alkyl-substituted aromatic radical, the aromatic radical of halogen substiuted, aralkyl heterocycle The miscellaneous alkanisation alkyl of base, cycloheteroalkyl or ring-type, R2Selected from alkyl, cycloalkyl, alkylhalide group or halogen cycloalkyl, described pair of carbonyl is also The amino acid sequence of protoenzyme such as one of following amino acid sequences:SEQ ID NO.1、SEQ ID NO.8、SEQ ID NO.12、SEQ Amino acid sequence shown in ID NO.16, SEQ ID NO.20, SEQ ID NO.24, SEQ ID NO.28 or SEQ ID NO.32 Row.
2. application according to claim 1, it is characterised in that the deoxynucleotide sequence of the coding di-carbonyl reduction enzyme Such as one of following deoxynucleotide sequence:SEQ ID NO.2、SEQ ID NO.5、SEQ ID NO.9、SEQ ID NO.13、SEQ Deoxynucleotide sequence shown in ID NO.17, SEQ ID NO.21, SEQ ID NO.25 or SEQ ID NO.29.
3. application according to claim 1, it is characterised in that the di-carbonyl reduction enzyme prepare 3R, 5S- dihydroxy- Application in 6- benzyloxies-hecanoic acid t-butyl ester.
4. application according to claim 1, it is characterised in that describedFor
CN201410188168.XA 2014-05-06 2014-05-06 Biscarbonyl reductase, and coding gene and application thereof Active CN103937759B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410188168.XA CN103937759B (en) 2014-05-06 2014-05-06 Biscarbonyl reductase, and coding gene and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410188168.XA CN103937759B (en) 2014-05-06 2014-05-06 Biscarbonyl reductase, and coding gene and application thereof

Publications (2)

Publication Number Publication Date
CN103937759A CN103937759A (en) 2014-07-23
CN103937759B true CN103937759B (en) 2017-03-22

Family

ID=51185633

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410188168.XA Active CN103937759B (en) 2014-05-06 2014-05-06 Biscarbonyl reductase, and coding gene and application thereof

Country Status (1)

Country Link
CN (1) CN103937759B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107603961B (en) * 2014-05-09 2020-04-24 凯莱英医药集团(天津)股份有限公司 Bischarbonylreductase mutant and application thereof
CN104560907B (en) * 2014-12-19 2017-12-22 凯莱英医药集团(天津)股份有限公司 Diketoreductase mutant and its application
WO2016095223A1 (en) * 2014-12-19 2016-06-23 凯莱英医药集团(天津)股份有限公司 Double-carbonyl reductase mutant and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344541B1 (en) * 1998-09-25 2002-02-05 Amgen Inc. DKR polypeptides
CN101429514B (en) * 2007-11-08 2011-06-15 陈依军 Di-carbonyl reduction enzyme, its gene and uses thereof
CN102277338A (en) * 2011-08-02 2011-12-14 中国药科大学 Diketoreductase mutant and application thereof

Also Published As

Publication number Publication date
CN103937759A (en) 2014-07-23

Similar Documents

Publication Publication Date Title
Gabor et al. Construction, characterization, and use of small‐insert gene banks of DNA isolated from soil and enrichment cultures for the recovery of novel amidases
Bresler et al. Gene cloning and nucleotide sequencing and properties of a cocaine esterase from Rhodococcus sp. strain MB1
KR20150020619A (en) Recombinant microorganisms and uses therefor
CN103937759B (en) Biscarbonyl reductase, and coding gene and application thereof
CN103703137B (en) The method being manufactured useful chemicals by p-phthalic acid potassium salt
CN103937761B (en) Biscarbonyl reductase, and coding gene and application thereof
CN104152500A (en) New method of biologically synthesizing (R)-3-hydroxylglutarate monoester
CN104498466B (en) nitrile hydratase and its application
KR101835160B1 (en) Stable aqueous acrylamide solution
WO2016095223A1 (en) Double-carbonyl reductase mutant and application thereof
WO2014073674A1 (en) Method for manufacturing useful substance in which high-density cultured strain of filamentous fungi is used
CN104560907B (en) Diketoreductase mutant and its application
CN103937760A (en) Biscarbonyl reductase, and coding gene and application thereof
JP2011041563A (en) Method for preserving microbial cell and suspension of microbial cell
US8735562B2 (en) Isolated fungal promoters and gene transcription terminators and methods of protein and chemical production in a fungus
CN100402640C (en) Process for producing lactonase and utilization thereof
KR100463966B1 (en) Preparation Of Dicarboxylic Acid Monoesters From Cyanocarboxylic Acid Esters
CN115261342A (en) Burkholderia BJQ 0011-derived ester synthetase JFN _18195, encoding gene and application thereof
KR101736018B1 (en) Method for preserving enzyme
CN101892228B (en) Engineering bacteria with high tolerance to acrylamide and acrylonitrile for producing nitrile hydratase and application thereof
JP4984925B2 (en) Aminoacylase gene
CN1242054A (en) Process and composition for preparing D-aspartic acid
CN104928265B (en) A kind of Ketoreductase mutant and its preparation and application
CA2217144A1 (en) Esterase gene and its use
RU2731289C2 (en) Method for constructing a biocatalyst strain based on bacteria of the genus rhodococcus, having nitrilase activity and high operational stability, recombinant strain of rhodococcus rhodochrous bacteria produced by such method, a method for synthesis of acrylic acid using this strain as a biocatalyst

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Hong Hao

Inventor after: James.Gaga

Inventor after: Chen Chaoyong

Inventor after: Zhou Yan

Inventor after: Gao Feng

Inventor after: Lv Tong

Inventor after: Guo Lina

Inventor before: Hong Hao

Inventor before: James.Gaga

Inventor before: Chen Chaoyong

Inventor before: Zhou Yan

Inventor before: Gao Feng

Inventor before: Lv Tong

Inventor before: Guo Lina

C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20200421

Address after: 300457 No. 6, Dongting street, Tianjin economic and Technological Development Zone, Binhai New Area

Co-patentee after: ASYMCHEM LIFE SCIENCE (TIANJIN) Co.,Ltd.

Patentee after: ASYMCHEM LABORATORIES (TIANJIN) Co.,Ltd.

Co-patentee after: ASYCHEM PHARMACEUTICALS (TIANJIN) Co.,Ltd.

Co-patentee after: ASYMCHEM LABORATORIES (FUXIN) Inc.

Co-patentee after: ASYMCHEM LABORATORIES (JILIN) Co.,Ltd.

Co-patentee after: Shanghai kailaiying Biotechnology Co., Ltd

Address before: 300457, No. 6, Dongting street, Tianjin economic and Technological Development Zone, Binhai New Area, Tianjin

Co-patentee before: ASYMCHEM LIFE SCIENCE (TIANJIN) Co.,Ltd.

Patentee before: ASYMCHEM LABORATORIES (TIANJIN) Co.,Ltd.

Co-patentee before: ASYCHEM PHARMACEUTICALS (TIANJIN) Co.,Ltd.

Co-patentee before: ASYMCHEM LABORATORIES (FUXIN) Inc.

Co-patentee before: ASYMCHEM LABORATORIES (JILIN) Co.,Ltd.

TR01 Transfer of patent right